Experimental Drug Shows Promise for Schizophrenia

Experimental Drug Shows Promise for Schizophrenia
Posted on Apr 16 2020
HealthDay
NAMI mentioned

An experimental drug may ease schizophrenia symptoms, without the side effects of existing medications, an early clinical trial suggests. Over one month, the drug helped manage a range of symptoms -- from delusions and hallucinations, to flattened emotions and social withdrawal. The drug, dubbed SEP-363856, also appeared to avoid the side effects common with standard antipsychotic medications. Dr. Ken Duckworth, CMO of NAMI said, "I'm glad to see they're investing in a drug with a new mechanism of action. And I'm cautiously optimistic about it."